1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Peru Pharmaceuticals and Healthcare Report Q4 2016

Peru Pharmaceuticals and Healthcare Report Q4 2016

  • October 2016
  • -
  • Business Monitor International
  • -
  • 88 pages

Includes 3 FREE quarterly updates

BMI View:

The presidential result, although unexpected, will not dampen the attractiveness of Peru's pharmaceutical and healthcare sectors which are forecast to experience strong growth over the coming years. Despite frequent clashes during the presidential race, Kuczynski has adopted a conciliatory tone in victory, and he and Fujimori broadly share a conservative agenda which seeks to usher in a new era of foreign investment and business growth. This will ensure government commitment to healthcare will continue to improve domestic pharmaceutical consumption.


Headline Expenditure Projections

- Pharmaceuticals: PEN4.98bn (USD1.56bn) in 2015 to PEN5.32bn (USD1.61bn) in 2016; +6.8% in local currency terms and +3.0% in US dollar terms. Forecast revised downward from previous quarter.

- Healthcare: PEN34.9bn (USD11.0bn) in 2015 to PEN38.5bn (USD11.7bn) in 2016; +10.1% in local currency terms and 6.2% in US dollar terms. Forecast revised downward from previous quarter.

Table Of Contents

Peru Pharmaceuticals and Healthcare Report Q4 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Peru 2014-2020) 7
SWOT 9
Industry Forecast 12
Pharmaceutical Market Forecast 12
Table: Pharmaceutical Sales, Historical Data And Forecasts (Peru 2012-2020) 14
Healthcare Market Forecast 15
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Peru 2012-2020) 17
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Peru 2012-2020) 17
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Peru 2012-2020) 18
Prescription Drug Market Forecast 19
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Peru 2012-2020) 20
Patented Drug Market Forecast 21
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Peru 2012-2020) 22
Generic Drug Market Forecast 23
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Peru 2012-2020) 25
OTC Medicine Market Forecast 26
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Peru 2012-2020) 27
Pharmaceutical Trade Forecast 28
Table: Pharmaceutical Trade Data And Forecasts (Peru 2014-2020) 30
Table: Pharmaceutical Trade Data And Forecasts local currency (Peru 2014-2020) 30
Industry Risk Reward Indices 31
Americas Risk/Reward Index 31
Peru Risk/Reward Index 38
Rewards 38
Risks 39
Regulatory Review 41
Intellectual Property Issues 43
Pricing Regime 45
Table: Peruvian Watchdog of Pharmaceutical Products (Observatorio Peruano de Productos Farmaceuticos, OPPF) 46
Reimbursement Regime 46
Table: Price Components Of Two Imported Medicines In Both Private And Public Sectors 47
Market Overview 48
Healthcare Sector 49
Table: MINSA's Decentralised Institutions and Institutes, 2015 49
Table: Healthcare Resources (Peru 2010-2015) 51
Table: Healthcare Personnel (Peru 2010-2015) 52
Table: Healthcare Activity (Peru 2010-2015) 52
Peru Pharmaceuticals and Healthcare Report Q4 2016$$
Research and Development 53
Clinical Trials 54
Epidemiology 55
Competitive Landscape 59
Research-Based Industry 59
Table: Multinational Market Activity 61
Table: Members of ADIFAN, 2014 62
Generic Drugmakers 62
Pharmaceutical Distribution 63
Pharmaceutical Retail Sector 64
Company Profile 67
Hersil 67
Novartis 70
Sanofi 72
Unimed 75
Demographic Forecast 77
Demographic Outlook 77
Table: Population Headline Indicators (Peru 1990-2025) 78
Table: Key Population Ratios (Peru 1990-2025) 78
Table: Urban/Rural Population and Life Expectancy (Peru 1990-2025) 79
Table: Population By Age Group (Peru 1990-2025) 79
Table: Population By Age Group % (Peru 1990-2025) 80
Glossary 82
Methodology 84
Pharmaceutical Expenditure Forecast Model 84
Healthcare Expenditure Forecast Model 84
Notes On Methodology 85
Risk/Reward Index Methodology 86
Index Overview 87
Table: Pharmaceutical Risk/Reward Index Indicators 87
Indicator Weightings 88

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.